IL6 and COVID-19: SARS-CoV-2 infection triggers inflammation in the microvascular endothelial cells in multiple organs, including the heart (85) as markers of endothelial inflammation - IL-6, TNF-α, IL-1β, IL-15 – were increased in the lungs of COVID-19 non-survivors (86).